SEC Form 3 · accession 0001209191-19-008770
Inmune Bio, Inc. · INMB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Xencor Inc
10% Owner
Period of report
Feb 1, 2019
Accepted (ET)
Feb 8, 2019 · 7:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001711754
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 1,585,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $7.80 | holding | — | — | — | — | Nov 15, 2027 | Common Stock | 108,000 | — | D |
Explanation of responses
- F1The shares subject to the option vest over 36 months beginning on April 3, 2018.